Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
A major new study on weight-loss drugs poses a new idea for addiction treatment: small doses of Ozempic could help people cut ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...
Read on to learn more about Ozempic, along with the conditions it’s approved to treat, eligibility requirements, approximate cost, safety concerns and more. Note that while other GLP-1 and ...
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.
People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.